Calendar

RECRUITINGphase readoutNCT07607678: A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Solid Cancer, Metastatic Solid Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05972343: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Sponsor: Washington University School of Medicine. Phase: . Conditions: Breast Cancer, Cancer of the Breast

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02810743: Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer

Sponsor: The Netherlands Cancer Institute. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07561515: Integrative Use of Sound Therapy for Mental Health Promotion

Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Sound Therapy, Music Therapy, Mental Health, Anxiety, Stress, Depression, Quality of Life, Acoustic Resonance, Insonia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07400315: First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric or Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07066215: Effects of Balance and Muscle Strength in Knee Osteoarthritis

Sponsor: Bezmialem Vakif University. Phase: . Conditions: Primary Knee Osteoarthritis

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07336615: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals

Sponsor: ClostraBio Inc.. Phase: NA. Conditions: Gastrointestinal, Overweight , Obesity

full page →ctgov ↗

RECRUITINGphase readoutNCT07477015: Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Autoimmune Encephalitis

full page →ctgov ↗

RECRUITINGphase readoutNCT06890078: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pneumocystis, Immunocompromised Patients

full page →ctgov ↗

COMPLETEDphase readoutNCT05348785: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Sponsor: Biogen. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06344143: Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

Sponsor: The Cleveland Clinic. Phase: . Conditions: Mild Autonomous Cortisol Secretion (MACS)

full page →ctgov ↗

RECRUITINGphase readoutNCT07114315: A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

Sponsor: Akeso. Phase: PHASE2. Conditions: Pancreatic Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05688215: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03059485: DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06309485: Phase 2 Study of WGI-0301 for Advanced HCC

Sponsor: Zhejiang Haichang Biotech Co., Ltd.. Phase: PHASE2. Conditions: Advanced Hepatocellular Carcinoma (HCC)

full page →ctgov ↗

RECRUITINGphase readoutNCT05849285: Evaluation of the Transitional and Lifelong Care Program

Sponsor: Western University, Canada. Phase: . Conditions: Cerebral Palsy, Spina Bifida, Developmental Disability

full page →ctgov ↗

COMPLETEDphase readoutNCT07501312: Remote Microphone Performance Comparison in Adults With Hearing Loss

Sponsor: Sonova AG. Phase: NA. Conditions: Hearing Loss

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07423312: Lead Exposure and Multiple Sclerosis

Sponsor: Assiut University. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07445828: Evaluation of Capsule Colonoscopy in Patients With Lynch Syndrome

Sponsor: Region Skane. Phase: . Conditions: Lynch Syndrome

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07352228: Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices

Sponsor: Xijing Hospital. Phase: PHASE4. Conditions: Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol

full page →ctgov ↗

COMPLETEDphase readoutNCT07429565: Testing APPA-1 in Healthy Subjects and Osteoarthritis Patients

Sponsor: University of Liverpool. Phase: PHASE1. Conditions: Osteoarthritis

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06731465: Efficiency, Efficacy, Periodontal & Occlusal Outcomes for Aligners Versus Fixed Orthodontic Appliances in Crowded Incisor Treatment

Sponsor: University of Sharjah. Phase: NA. Conditions: Crowding of Anterior Mandibular Teeth

full page →ctgov ↗

COMPLETEDphase readoutNCT03194165: Population Pharmacokinetics of Antiretroviral in Children

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed

full page →ctgov ↗

RECRUITINGphase readoutNCT00756665: Prostate Active Surveillance Study

Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms

full page →ctgov ↗

COMPLETEDphase readoutNCT07500467: Upadacitinib for Refractory Takayasu Arteritis

Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis

full page →ctgov ↗

COMPLETEDphase readoutNCT04681807: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗

COMPLETEDphase readoutNCT04993807: Data-driven SDM to Reduce Symptom Burden in AF

Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement

full page →ctgov ↗

RECRUITINGphase readoutNCT06442592: Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07455136: A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury

full page →ctgov ↗

COMPLETEDphase readoutNCT06953336: Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant

full page →ctgov ↗

RECRUITINGphase readoutNCT05361811: Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07282171: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

Sponsor: Comanche Biopharma. Phase: PHASE1. Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia

full page →ctgov ↗

RECRUITINGphase readoutNCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics

full page →ctgov ↗

COMPLETEDphase readoutNCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Sponsor: Sun Pharmaceutical Industries Limited. Phase: PHASE3. Conditions: Active Psoriatic Arthritis

full page →ctgov ↗

RECRUITINGphase readoutNCT07195864: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

Sponsor: SIFI SpA. Phase: . Conditions: Acanthamoeba Keratitis

full page →ctgov ↗

RECRUITINGphase readoutNCT05786664: Breast Cancer Survivorship Biorepository

Sponsor: University of Southern California. Phase: . Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07320209: Physiological and Neurocognitive Responses to Multisensory Food Cues in VR

Sponsor: Marmara University. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗

COMPLETEDphase readoutNCT07609732: Outcomes of Conventional Root Canal Treatment Compared to Regenerative Endodontics, and Cleaning and Shaping Only in Mature Upper First Premolars

Sponsor: Ain Shams University. Phase: NA. Conditions: Regenerative Endodontic Treatment, Cleaning and Shaping Only With Proper Coronal Seal, Necrotic Mature First Premolar

full page →ctgov ↗

RECRUITINGphase readoutNCT07398898: Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Dental Anxiety, Music Therapy, Oral Surgical Procedures

full page →ctgov ↗

RECRUITINGphase readoutNCT07424963: Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

Sponsor: Military University Hospital, Prague. Phase: NA. Conditions: Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient

full page →ctgov ↗

RECRUITINGphase readoutNCT03571763: The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

Sponsor: General Hospital of Shenyang Military Region. Phase: . Conditions: Ischemic Stroke

full page →ctgov ↗

COMPLETEDphase readoutNCT05352893: Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Pustular Psoriasis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02641093: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Sponsor: Trisha Wise-Draper. Phase: PHASE2. Conditions: Head and Neck Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07334821: Diagnostic Performance of PIC Cystogram vs VCUG in Children

Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Pediatric Urology

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07494721: Effects of Training With a Pressure Cuff on Cellular Energy Activity

Sponsor: Spital Thurgau AG. Phase: NA. Conditions: Physical Deconditioning

full page →ctgov ↗

COMPLETEDphase readoutNCT05425316: Speech in Hepatic Encephalopathy (HE)

Sponsor: University of Michigan. Phase: . Conditions: Hepatic Encephalopathy

full page →ctgov ↗

COMPLETEDphase readoutNCT01787500: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7, Unresectable Solid Neoplasm

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04739800: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Fallopian Tube Mucinous Adenocarcinoma, Recurrent Fallopian Tube Transitional Cell Carcinoma, Recurrent Fallopian Tube Undifferentiated Carcinoma, Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Ovarian Mucinous Adenocarcinoma, Recurrent Ovarian Seromucinous Carcinoma, Recurrent Ovarian Transitional Cell Carcinoma, Recurrent Ovarian Undifferentiated Carcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Clear Cell Adenocarcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Transitional Cell Carcinoma, Recurrent Primary Peritoneal Undifferentiated Carcinoma, Refractory Fallopian Tube Clear Cell Adenocarcinoma, Refractory Fallopian Tube Endometrioid Adenocarcinoma, Refractory Fallopian Tube High Grade Serous Adenocarcinoma, Refractory Fallopian Tube Mucinous Adenocarcinoma, Refractory Fallopian Tube Transitional Cell Carcinoma, Refractory Fallopian Tube Undifferentiated Carcinoma, Refractory Low Grade Fallopian Tube Serous Adenocarcinoma, Refractory Ovarian Clear Cell Adenocarcinoma, Refractory Ovarian Endometrioid Adenocarcinoma, Refractory Ovarian High Grade Serous Adenocarcinoma, Refractory Ovarian Low Grade Serous Adenocarcinoma, Refractory Ovarian Mucinous Adenocarcinoma, Refractory Ovarian Seromucinous Carcinoma, Refractory Ovarian Transitional Cell Carcinoma, Refractory Ovarian Undifferentiated Carcinoma, Refractory Primary Peritoneal Clear Cell Adenocarcinoma, Refractory Primary Peritoneal Endometrioid Adenocarcinoma, Refractory Primary Peritoneal High Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Transitional Cell Carcinoma, Refractory Primary Peritoneal Undifferentiated Carcinoma

COMPLETEDphase readoutNCT06733207: Pupillometry Use & Professional's Inspection : Leveling Subjectivity

Sponsor: CHU de Reims. Phase: . Conditions: Intensive Care, Pupil Assessment, Pupillometry, Neurological Examination, Clinical Competence, Nursing Assessment, Diagnostic Techniques and Procedures, Comparative Effectiveness Research, Interprofessional Relations, Observer Variation

full page →ctgov ↗

Date TBD